MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The utility of DCTclock™ (the digital clock drawing test) for unmasking early cognitive decline in Parkinson’s disease

    T. Schejter Margalit, R. Kizony, B. Cohen, A. Thaler, W. Souillard-Mandar, A. Holway, V. Irzhevsky, A. Orr-Urtreger, J. Cederbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the utility of DCTclock, for assessing subtle cognitive impairments in early Parkinson's disease (PD). Background: The identification of cognitive decline is crucial…
  • 2019 International Congress

    Movement disorders spectrum in patients with frontotemporal dementia

    YU. Shpilyukova, E. Fedotova, D. Grishina, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To determine frequency of different hypokinetic and hyperkinetic movement disorders (MD) within a spectrum of frontotemporal dementia (FTD): we examined patients with behavioral and…
  • 2019 International Congress

    Cognitive impairment in Parkinson’s Disease: A cross-sectional association study

    A. Simon, C. Rodriguez-Blazquez, MJ. Forjaz, P. Martinez-Martin (Madrid, Spain)

    Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study

    N. Sousa, R. Macedo, S. Brucki (Salvador, Brazil)

    Objective: To investigate the relationships between cognitive ability (global and single domain-executive functions) and gait performance (balance, gait speed and mobility) in patients with Parkinson's…
  • 2019 International Congress

    Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

    N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)

    Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…
  • 2019 International Congress

    Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis

    A. Surendranathan, J. Kane, A. Bentley, S. Barker, J. Taylor, A. Thomas, I. Mckeith, D. Burn, J. O'Brien (Cambridge, United Kingdom)

    Objective: To assess whether diagnostic rates of both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) could be increased by the introduction of…
  • 2019 International Congress

    Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong

    V. Tang, D. Chan, XL. Zhu, D. Chan, C. Lau, A. Chan, K. Ma, J. Yeung, V. Mok, W. Poon (N.t., Hong Kong)

    Objective: The study aimed to examine the neurocognitive changes following STN-DBS in patients with PD. Background: Neurocognitive evaluation is a standard procedure preoperatively in patients…
  • 2019 International Congress

    Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

    Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…
  • 2019 International Congress

    Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment

    M. Todisco, P. Vitali, B. Minafra, F. Avantaggiato, R. Zangaglia, NG. Pozzi, R. Ceravolo, C. Pacchetti (Pavia, Italy)

    Objective: To explore the relationship between vascular subcortical encephalopathy, ventricular dilation and clinical severity in idiopathic normal pressure hydrocephalus (iNPH). Background: The frequent co-occurrence of…
  • 2019 International Congress

    Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease

    T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: To investigate whether susceptibility loci for Alzheimer's disease (AD) are associated with rates of longitudinal cognitive decline in Parkinson’s disease (PD). Background: Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 1145
  • 1146
  • 1147
  • 1148
  • 1149
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley